NewsRx

Search our medical news database

Avant Immunotherapeutics

Avant receives $4M milestone payment from GlaxoSmithKline for rotavirus vaccine

Published in Law and Health Weekly, April 8th, 2006

Avant Immunotherapeutics (AVAN) has received a $4 million milestone payment from GlaxoSmithKline (GSK).

This payment marks the approval from the European Commission for Rotarix in the European Union (E.U.). Rotarix will be the first rotavirus vaccine available to children in Europe for the prevention of gastroenteritis caused by rotavirus.

"We are very gratified to receive this milestone payment, which marks a key event in the worldwide commercialization of Rotarix," said Una S. Ryan, PhD, Avant president and CEO. "This approval also leads to a substantial payment of $40 million to Avant through its transaction with Paul Royalty Fund [PRF]."

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook